• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, February 8, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Researchers lengthen intervals between blood draws for warfarin patients

Bioengineer by Bioengineer
June 4, 2018
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new study finds stable patients on blood thinners may not need to get their blood drawn as often as they currently do. Researchers were able to increase the number of people waiting longer than five weeks in between their INR blood draws from less than half (41.8%) to more than two-thirds (69.3%).

"Warfarin patients with good INR control could have fewer blood draws, less discomfort and less cost," says Geoffrey Barnes, M.D., first author and cardiologist at the University of Michigan's Frankel Cardiovascular Center.

###

The U-M team published the new research in the Journal of Thrombosis and Haemostasis, thanks to participation in the Michigan Anticoagulation Quality Improvement Initiative (one of Blue Cross Blue Shield of Michigan's Collaborative Quality Initiatives). The paper studied 890 stable warfarin-treated patients in Michigan.

DOI: 10.1111/jth.14150

Media Contact

Haley Otman
[email protected]
734-764-2220
@umichmedicine

http://www.med.umich.edu

http://dx.doi.org/10.1111/jth.14150

Share12Tweet7Share2ShareShareShare1

Related Posts

Barriers and Facilitators to Smoking Cessation for HIV+ Men

February 8, 2026

Community Involvement Eases Depression in China’s Empty Nesters

February 8, 2026

Group Therapy Boosts Recovery in Elderly Depression

February 8, 2026

Evaluating Biosimilar Trastuzumab for Breast Cancer in Thailand

February 8, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13
  • Mapping Tertiary Lymphoid Structures for Kidney Cancer Biomarkers

    50 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Barriers and Facilitators to Smoking Cessation for HIV+ Men

Community Involvement Eases Depression in China’s Empty Nesters

Group Therapy Boosts Recovery in Elderly Depression

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 74 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.